Why is Teva useful for the platform?
Because it adds healthcare diversification and a globally recognized Israeli name.
Forecasting and modeling
Teva adds healthcare and pharmaceuticals to the site’s equity coverage, making the platform less dependent on technology and financials alone. As a flagship Israeli name, it is useful both as a local market component and as a globally followed healthcare stock.
Teva is usually driven by product and pipeline news, litigation and balance-sheet themes, healthcare sentiment, global defensives positioning and the tone of the local Israeli equity market.
Read this page as a short-horizon signal on a large Israeli healthcare name. Event sensitivity often matters as much as the headline directional tilt.
| Date | ML target | Raw interval (bands) | Signal |
|---|---|---|---|
| 26.10.2026 (Mon) | 30.64 | [29.80 - 31.49] | BUY |
| 27.10.2026 (Tue) | 30.81 | [29.63 - 32.03] | BUY |
| 28.10.2026 (Wed) | 30.97 | [29.53 - 32.49] | BUY |
| 29.10.2026 (Thu) | 31.14 | [29.47 - 32.91] | BUY |
| 30.10.2026 (Fri) | 31.32 | [29.44 - 33.31] | BUY |
| 02.11.2026 (Mon) | 31.49 | [29.43 - 33.69] | BUY |
| 03.11.2026 (Tue) | 31.66 | [29.43 - 34.06] | BUY |
| 04.11.2026 (Wed) | 31.83 | [29.45 - 34.42] | BUY |
| 05.11.2026 (Thu) | 32.01 | [29.47 - 34.77] | BUY |
| 06.11.2026 (Fri) | 32.18 | [29.50 - 35.12] | BUY |
| 09.11.2026 (Mon) | 32.36 | [29.53 - 35.46] | BUY |
| 10.11.2026 (Tue) | 32.54 | [29.58 - 35.80] | BUY |
| 11.11.2026 (Wed) | 32.72 | [29.62 - 36.14] | BUY |
| 12.11.2026 (Thu) | 32.90 | [29.67 - 36.47] | BUY |
| 13.11.2026 (Fri) | 33.08 | [29.73 - 36.80] | BUY |
| 16.11.2026 (Mon) | 33.26 | [29.79 - 37.14] | BUY |
| 17.11.2026 (Tue) | 33.44 | [29.85 - 37.47] | BUY |
| 18.11.2026 (Wed) | 33.63 | [29.91 - 37.80] | BUY |
| 19.11.2026 (Thu) | 33.81 | [29.98 - 38.13] | BUY |
| 20.11.2026 (Fri) | 34.00 | [30.05 - 38.46] | BUY |
| 23.11.2026 (Mon) | 34.18 | [30.13 - 38.78] | BUY |
| 24.11.2026 (Tue) | 34.37 | [30.20 - 39.11] | BUY |
| 25.11.2026 (Wed) | 34.56 | [30.28 - 39.44] | BUY |
| 26.11.2026 (Thu) | 34.75 | [30.36 - 39.77] | BUY |
| 27.11.2026 (Fri) | 34.94 | [30.44 - 40.10] | BUY |
| 30.11.2026 (Mon) | 35.13 | [30.52 - 40.43] | BUY |
| 01.12.2026 (Tue) | 35.32 | [30.61 - 40.76] | BUY |
| 02.12.2026 (Wed) | 35.52 | [30.70 - 41.10] | BUY |
| 03.12.2026 (Thu) | 35.71 | [30.79 - 41.43] | BUY |
| Horizon end | ML target | Delta | Raw interval (bands) | Signal |
|---|---|---|---|---|
| 25.01.2027 (1 quarter) | 36.62 | +20.20% | [29.41 - 45.07] | BUY |
| 25.04.2027 (6 months) | 37.72 | +23.81% | [26.52 - 52.10] | BUY |
| 25.10.2027 (1 year) | 40.09 | +31.57% | [23.42 - 64.23] | BUY |
Because it adds healthcare diversification and a globally recognized Israeli name.
As a short-term directional lean into the currently displayed horizon close, paired with event sensitivity and volatility.
Because pharmaceutical names can move sharply on legal, pipeline or product headlines.
To see whether the move is broad-market driven or company-specific.